English | 繁體

Search in the results

UM

Browse/Search Results:  1-9 of 9 Help

Selected(0)Clear Items/Page:    Sort:
Bispecific antibodies targeting two glycoproteins on SFTSV exhibit synergistic neutralization and protection in a mouse model Journal article
Chang, Zhen, Gao, Dan, Liao, Liying, Sun, Junqing, Zhang, Gen, Zhang, Xue, Wang, Feiran, Li, Chunrui, Oladejo, Babayemi Olawale, Li, Shihua, Chai, Yan, Hu, Yongfei, Lu, Xuancheng, Xiao, Haixia, Qi, Jianxun, Chen, Zhihai, Gao, Feng, Wu, Yan. Bispecific antibodies targeting two glycoproteins on SFTSV exhibit synergistic neutralization and protection in a mouse model[J]. Proceedings of the National Academy of Sciences of the United States of America, 2024, 121(24), e2400163121.
Authors:  Chang, Zhen;  Gao, Dan;  Liao, Liying;  Sun, Junqing;  Zhang, Gen; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:9.4/10.8 | Submit date：2024/07/04
Bispecific Antibody  Bunyavirus  Glycoproteins  Sftsv  Structural Basis  
Editorial: Therapeutic antibody domains against cancer Other
2023-08-28
Authors:  Zhao, Qi;  Li, Wei;  Dimitrov, Dimiter S.
Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date：2023/08/30
Antibody Domain  Bispecific Antibody  Cancer  Immune Checkpoint  Monoclonal Antibody  Phage Display  
Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes Journal article
Liu, J., Yang, S., Cao, B., Zhou , G., Zhang, F., Wang, Y., Wang, R., Zhu, L., Meng, Y., Hu, C., Liang, H., Lin, X., Zhu, K., Chen, G., Luo, K.Q., Di, L., Zhao, Q.. Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes[J]. Journal of Hematology & Oncology, 2021, 14(1), 1-18.
Authors:  Liu, J.;  Yang, S.;  Cao, B.;  Zhou , G.;  Zhang, F.; et al.
Favorite | TC[WOS]:60 TC[Scopus]:64 | Submit date：2022/08/26
B7-h3  Chimeric Antigen Receptor  Bispecific Antibody  Non-small Cell Lung  
Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes Journal article
Liu, Jie, Yang, Shuo, Cao, Bihui, Zhou, Guangyu, Zhang, Fengjuan, Wang, Yuan, Wang, Rixin, Zhu, Lipeng, Meng, Ya, Hu, Cong, Liang, Hui, Lin, Xu, Zhu, Kangshun, Chen, Guokai, Luo, Kathy Qian, Di, Lijun, Zhao, Qi. Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes[J]. Journal of Hematology and Oncology, 2021, 14(1), 1-18.
Authors:  Liu, Jie;  Yang, Shuo;  Cao, Bihui;  Zhou, Guangyu;  Zhang, Fengjuan; et al.
Favorite | TC[WOS]:60 TC[Scopus]:64  IF:29.5/26.9 | Submit date：2021/03/04
B7-h3  Bike  Bispecific Antibody  Car t  Chimeric Antigen Receptor  Non-small Cell Lung Cancer  Pd-l1  
Bispecific antibodies for autoimmune and inflammatory diseases: clinical progress to date Journal article
Zhao, Q.. Bispecific antibodies for autoimmune and inflammatory diseases: clinical progress to date[J]. BioDrugs, 2020, 111-119.
Authors:  Zhao, Q.
Favorite |   IF:5.4/5.3 | Submit date：2023/08/25
Bispecific antibody  autoimmune diseases  
A native-like bispecific antibody suppresses the inflammatory cytokine response by simultaneously neutralizing tumor necrosis factor-alpha and interleukin-17A Journal article
Xu, Tianshu, Ying, Tianlei, Wang, Lili, Zhang, Xiaohua Douglas, Wang, Ying, Kang, Lishan, Huang, Tao, Cheng, Liang, Wang, Liping, Zhao, Qi. A native-like bispecific antibody suppresses the inflammatory cytokine response by simultaneously neutralizing tumor necrosis factor-alpha and interleukin-17A[J]. ONCOTARGET, 2017, 8(47), 81860-81872.
Authors:  Xu, Tianshu;  Ying, Tianlei;  Wang, Lili;  Zhang, Xiaohua Douglas;  Wang, Ying; et al.
Favorite | TC[WOS]:22 TC[Scopus]:21  IF:5.168/5.312 | Submit date：2018/10/30
Bispecific Antibody  Fc Heterodimerization  Tnf-alpha  Il-17  Rheumatoid Arthritis  Immunology And Microbiology Section  Immune Response  Immunity  
Generation of Bispecific Antibodies by Fc Heterodimerization and their Application Journal article
Chen, Z., Wang, L, Xu, T, Wang, Q, Kang, L, Zhao, Q.. Generation of Bispecific Antibodies by Fc Heterodimerization and their Application[J]. Current Pharmaceutical Biotechnology, 2016, 1324-1332.
Authors:  Chen, Z.;  Wang, L;  Xu, T;  Wang, Q;  Kang, L; et al.
Favorite |   IF:2.2/2.4 | Submit date：2023/08/30
Bispecific antibody  Fc heterodimerization  quadroma  Knobs-into-holes  strand-exchange engineered domain  
Generation of bispecific antibodies by Fc heterodimerization and their application Journal article
Chen, ZZ, Wang, LP, Xu, TS, Wang, QF, Kang, LS, Zhao, Q. Generation of bispecific antibodies by Fc heterodimerization and their application[J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2016, 17(15), 1324-1332.
Authors:  Chen, ZZ;  Wang, LP;  Xu, TS;  Wang, QF;  Kang, LS; et al.
Favorite | TC[WOS]:10 TC[Scopus]:10  IF:2.2/2.4 | Submit date：2019/01/23
Bispecific Antibody  Fc Heterodimerization  Quadroma  Knobs-into-holes  Strand-exchange Engineered Domain  
Soluble expression, purification and bioactivity assay of anti-ovarian carcinoma x anti-CD3 x anti-CD28VH single chain trispecific antibody Journal article
Zhao, B., Wang, X., Zhao, Q., Wang, S., Huang, H.. Soluble expression, purification and bioactivity assay of anti-ovarian carcinoma x anti-CD3 x anti-CD28VH single chain trispecific antibody[J]. Chinese Journal of Microbiology and Immunology, 2004, 475-479.
Authors:  Zhao, B.;  Wang, X.;  Zhao, Q.;  Wang, S.;  Huang, H.
Favorite |  | Submit date：2023/08/30
Bispecific Antibodies  Blinatumomab  Single Chain Fragment Variable Antibody